Compare CELZ & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CELZ | TKLF |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8M | 8.2M |
| IPO Year | 2008 | 2020 |
| Metric | CELZ | TKLF |
|---|---|---|
| Price | $2.13 | $1.97 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 40.3K | ★ 110.8K |
| Earning Date | 05-08-2026 | 12-19-2025 |
| Dividend Yield | N/A | ★ 10.97% |
| EPS Growth | ★ 32.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $6,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $2.82 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $1.76 |
| 52 Week High | $6.25 | $4.32 |
| Indicator | CELZ | TKLF |
|---|---|---|
| Relative Strength Index (RSI) | 47.70 | 46.33 |
| Support Level | $2.07 | $1.92 |
| Resistance Level | $2.41 | $2.41 |
| Average True Range (ATR) | 0.11 | 0.22 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 42.08 | 46.94 |
Creative Medical Technology Holdings Inc is a commercial-stage biotechnology company focused on the advancement of regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics. Its pipeline consists of AlloStem (CELZ-201-DDT); ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, an intervention for the treatment of recent onset Type 1 Diabetes; AlloStemSpine for treatment of lower back pain; the Alova program to treat infertility as a result of premature ovarian failure; and other regenerative treatment programs and technologies like OvaStem, CaverStem, FemCelz, StemSpine, and others for the treatment of various indications related to sexual health, spine disc disease, kidney failure, liver failure, etc.
Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.